Evidence map›Paper›PMID 42557395›Full record

ArticleBiomechanics and modeling in mechanobiology2026

A modelling study of right ventricular growth with valvular regurgitation.

Debao Guan, Hao Gao

Abstract read
In one paragraph

Article in Biomechanics and modeling in mechanobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Debao GuanSchool of Control Science and Engineering, Shandong University, Jinan, China.
Hao GaoSchool of Mathematics and Statistics, University of Glasgow, Glasgow, UK. hao.gao@glasgow.ac.uk.ORCID https://orcid.org/0000-0001-6852-9435

Funding

British Heart Foundation PG/22/10930Engineering and Physical Sciences Research Council EP/Z531182/1
6 · The paper itself

Abstract

Right ventricular (RV) dysfunction due to pulmonary and tricuspid valve regurgitation remains understudied despite its critical role in adverse cardiac outcomes. We present a biventricular computational model that integrates regurgitant valves in the RV with a kinematic growth framework. Updated reference configurations are used to allow saturated growth in each growth cycle. Acute regurgitation scenarios and long-term adaptation are modelled to quantify structural and functional adaptations in the RV and their further impacts on left ventricular (LV) performance. Results demonstrate that persistent regurgitation drives dominant eccentric growth in the RV, leading to severe cavity dilation, septal displacement, and impaired LV filling and systolic function. Simulations incorporating both eccentric and concentric growth reveal a limited compensatory role for concentric thickening, even under severe volume overload. The simulated haemodynamic and functional responses are broadly consistent with clinical observations and capture clinically plausible trajectories of RV growth under sustained regurgitation. These findings suggest that biomechanical modelling of myocardial adaptation could provide mechanistic insights into RV adaptation under severe valve regurgitation, and may support clinical decision-making regarding RV failure once fully validated. Future work should focus on validating myocardial growth laws using experimental and clinical data, and extending the framework to patient-specific scenarios for predictive modelling of RV dysfunction due to valve regurgitation.

Indexed as

Heart VentriclesModels, CardiovascularBiomechanical PhenomenaComputer SimulationHemodynamicsHumansComputational modellingEccentric growthKinematic growthRight ventricleValvular regurgitation

Identifiers

PMID42557395
PMCPMC13442517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.